Z Squared ZSQR
NASDAQ ZSQR
$2.58 +0.28 (+11.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Z Squared (ZSQR) Gross Margin (2025 - 2026)

Updated

Z Squared's Gross Margin was -111.52% in Q2 2026, down 171.83 percentage points from the prior quarter.

Analysis

Z Squared (ZSQR) Gross Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Z Squared's Gross Margin was -24.61% through Jun 30, 2026, down 52.79 percentage points year-over-year; for FY2025, it was 86.75%.

  • Gross Margin shows a four-year change of -13.25 percentage points (FY2021 to FY2025).
  • In earlier years, Gross Margin was 100.00% in FY2021.
  • Per Business Quant data, ZSQR's Gross Margin in the three quarters before Q2 2026 was 60.31% (Q1 2026), 94.76% (Q4 2025) and 80.98% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 Z Squared 121.90 Mn 95.14 Mn -1.77 Mn -111.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -111.52%
Mar 31, 2026 60.31%
Dec 31, 2025 94.76%
Sep 30, 2025 80.98%
Mar 31, 2025 28.18%
API Access

Z Squared Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ZSQR&period=max&api_key=YOUR_API_KEY